BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 18036669)

  • 21. Aging, plasticity and environmental enrichment: structural changes and neurotransmitter dynamics in several areas of the brain.
    Mora F; Segovia G; del Arco A
    Brain Res Rev; 2007 Aug; 55(1):78-88. PubMed ID: 17561265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GABAA receptors in the mediodorsal thalamus play a crucial role in rat shell-specific acetylcholine-mediated, but not dopamine-mediated, turning behaviour.
    Ikeda H; Kotani A; Lee J; Koshikawa N; Cools AR
    Neuroscience; 2009 Apr; 159(4):1200-7. PubMed ID: 19217930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Zonisamide enhances delta receptor-associated neurotransmitter release in striato-pallidal pathway.
    Yamamura S; Ohoyama K; Nagase H; Okada M
    Neuropharmacology; 2009 Sep; 57(3):322-31. PubMed ID: 19482038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A post mortem study on neurochemical markers of dopaminergic, GABA-ergic and glutamatergic neurons in basal ganglia-thalamocortical circuits in Parkinson syndrome.
    Gerlach M; Gsell W; Kornhuber J; Jellinger K; Krieger V; Pantucek F; Vock R; Riederer P
    Brain Res; 1996 Nov; 741(1-2):142-52. PubMed ID: 9001716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Receptor-receptor interactions within receptor mosaics. Impact on neuropsychopharmacology.
    Fuxe K; Marcellino D; Rivera A; Diaz-Cabiale Z; Filip M; Gago B; Roberts DC; Langel U; Genedani S; Ferraro L; de la Calle A; Narvaez J; Tanganelli S; Woods A; Agnati LF
    Brain Res Rev; 2008 Aug; 58(2):415-52. PubMed ID: 18222544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simulation of GABA function in the basal ganglia: computational models of GABAergic mechanisms in basal ganglia function.
    Wickens JR; Arbuthnott GW; Shindou T
    Prog Brain Res; 2007; 160():313-29. PubMed ID: 17499122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effect of aging on synaptic plasticity in the ventral and dorsal striatum.
    Wang Y
    Neurobiol Learn Mem; 2008 Jan; 89(1):70-5. PubMed ID: 17942327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced glutamatergic phenotype of mesencephalic dopamine neurons after neonatal 6-hydroxydopamine lesion.
    Dal Bo G; Bérubé-Carrière N; Mendez JA; Leo D; Riad M; Descarries L; Lévesque D; Trudeau LE
    Neuroscience; 2008 Sep; 156(1):59-70. PubMed ID: 18706980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Motor cortical control of internal pallidal activity through glutamatergic and GABAergic inputs in awake monkeys.
    Tachibana Y; Kita H; Chiken S; Takada M; Nambu A
    Eur J Neurosci; 2008 Jan; 27(1):238-53. PubMed ID: 18093168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On the neuronal circuitries and neurotransmitters involved in the control of locomotor activity.
    Carlsson A
    J Neural Transm Suppl; 1993; 40():1-12. PubMed ID: 7905022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Controlled cell targeting system to study the brain neural circuitry.
    Kobayashi K
    Neurosci Res; 2007 Jun; 58(2):118-23. PubMed ID: 17313983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Motor activity is modulated via different neuronal circuits in rats with chronic liver failure than in normal rats.
    Cauli O; Mlili N; Llansola M; Felipo V
    Eur J Neurosci; 2007 Apr; 25(7):2112-22. PubMed ID: 17439495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking.
    Monti JM; Jantos H
    Prog Brain Res; 2008; 172():625-46. PubMed ID: 18772053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presynaptic metabotropic glutamate receptors regulate glutamatergic input to dopamine neurons in the ventral tegmental area.
    de Rover M; Meye FJ; Ramakers GM
    Neuroscience; 2008 Jul; 154(4):1318-23. PubMed ID: 18534761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physiology of the normal and dopamine-depleted basal ganglia: insights into levodopa pharmacotherapy.
    Grace AA
    Mov Disord; 2008; 23 Suppl 3():S560-9. PubMed ID: 18781673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neural circuitry models of schizophrenia: is it dopamine, GABA, glutamate, or something else?
    Benes FM
    Biol Psychiatry; 2009 Jun; 65(12):1003-5. PubMed ID: 19481640
    [No Abstract]   [Full Text] [Related]  

  • 37. Neurotransmitters and their receptors in the basal ganglia.
    McGeer PL; McGeer EG
    Adv Neurol; 1993; 60():93-101. PubMed ID: 8093584
    [No Abstract]   [Full Text] [Related]  

  • 38. GABAergic circuits in the basal ganglia and movement disorders.
    Galvan A; Wichmann T
    Prog Brain Res; 2007; 160():287-312. PubMed ID: 17499121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-localization of GABA with other neuroactive substances in the basal ganglia.
    McGinty JF
    Prog Brain Res; 2007; 160():273-84. PubMed ID: 17499120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of glutamate and its receptors in mesocorticolimbic dopaminergic regions in opioid addiction.
    Guo Y; Wang HL; Xiang XH; Zhao Y
    Neurosci Biobehav Rev; 2009 Jun; 33(6):864-73. PubMed ID: 19428497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.